Horizon Pharma Plc.'s ticker is and the CUSIP is 00BQPVQZ6. A total of 1 filers reported holding Horizon Pharma Plc. in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,099,000 | -22.5% | 17,759 | -0.1% | 0.02% | -16.7% |
| Q2 2022 | $1,418,000 | -25.8% | 17,784 | -2.1% | 0.02% | -10.0% |
| Q1 2022 | $1,911,000 | -0.4% | 18,167 | +2.1% | 0.02% | +5.3% |
| Q4 2021 | $1,918,000 | -1.3% | 17,797 | +0.3% | 0.02% | 0.0% |
| Q3 2021 | $1,943,000 | +0.8% | 17,742 | -13.8% | 0.02% | 0.0% |
| Q2 2021 | $1,927,000 | -0.8% | 20,578 | -2.5% | 0.02% | -5.0% |
| Q1 2021 | $1,942,000 | -49.6% | 21,097 | -60.0% | 0.02% | -54.5% |
| Q4 2020 | $3,856,000 | -7.9% | 52,708 | -2.2% | 0.04% | -21.4% |
| Q3 2020 | $4,188,000 | -12.2% | 53,908 | -37.2% | 0.06% | -16.4% |
| Q2 2020 | $4,771,000 | +51.2% | 85,837 | -19.4% | 0.07% | +26.4% |
| Q1 2020 | $3,156,000 | -59.4% | 106,551 | -50.4% | 0.05% | -46.5% |
| Q4 2019 | $7,781,000 | +43.0% | 214,944 | +7.5% | 0.10% | +30.3% |
| Q3 2019 | $5,443,000 | +8.0% | 199,876 | +4.8% | 0.08% | +4.1% |
| Q1 2019 | $5,042,000 | +64.3% | 190,763 | +21.5% | 0.07% | +43.1% |
| Q4 2018 | $3,068,000 | -0.2% | 157,000 | 0.0% | 0.05% | +15.9% |
| Q3 2018 | $3,074,000 | +104.0% | 157,000 | +72.5% | 0.04% | +100.0% |
| Q2 2018 | $1,507,000 | +63.8% | 91,000 | +46.1% | 0.02% | +37.5% |
| Q1 2017 | $920,000 | – | 62,268 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DnB Asset Management AS | 44,428 | $5,055,906 | 0.04% |